External beam radiation for HCC: Ready for incorporation into guidelines?
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: an effective, low cost, and globally available treatment that can dramatically improve outcomes
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This review details the current best evidence available and makes a compelling case that external beam radiation therapy should be included in clinical guidelines. Doing so will benefit patients with an effective, low cost, and globally available treatment that can dramatically improve outcomes.
External beam radiation therapy is becoming an increasingly useful tool in the management of hepatocellular carcinoma at all clinical stages.
APA
Buckstein M, Dawson LA (2026). External beam radiation for HCC: Ready for incorporation into guidelines?. JHEP reports : innovation in hepatology, 8(2), 101683. https://doi.org/10.1016/j.jhepr.2025.101683
MLA
Buckstein M, et al.. "External beam radiation for HCC: Ready for incorporation into guidelines?." JHEP reports : innovation in hepatology, vol. 8, no. 2, 2026, pp. 101683.
PMID
41551406 ↗
Abstract 한글 요약
External beam radiation therapy is becoming an increasingly useful tool in the management of hepatocellular carcinoma at all clinical stages. The data supporting its use is now maturing, with randomised trials showing excellent results in early, intermediate, advanced, and palliative stages. This review details the current best evidence available and makes a compelling case that external beam radiation therapy should be included in clinical guidelines. Doing so will benefit patients with an effective, low cost, and globally available treatment that can dramatically improve outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study.
- CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models.
- SIRT Combined with Targeted Therapy and Immunotherapy Achieves Sustained Complete Remission in Advanced Hepatocellular Carcinoma: A Case Report.
- The Novel HSF1 Inhibitor NXP800 Exhibits Robust Antitumor Activity in Hepatocellular Carcinoma.
- TATA-box binding protein-associated factor 2 (TAF2) in hepatocyte survival and tumorigenesis.
- B-mode and contrast-enhanced ultrasound versus magnetic resonance imaging in hepatic angiomyolipoma: a case report.